ACT CAPITAL MANAGEMENT, LLC - INHIBIKASE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$853,000
+22.6%
937,5000.0%1.18%
+21.0%
Q2 2022$696,000
-56.3%
937,500
-12.9%
0.97%
-42.3%
Q1 2022$1,593,000
+0.7%
1,076,5000.0%1.68%
+47.3%
Q4 2021$1,582,000
-17.6%
1,076,500
+6.6%
1.14%
+15.0%
Q3 2021$1,919,000
-21.7%
1,010,000
+15.4%
1.00%
-21.0%
Q2 2021$2,450,000875,0001.26%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders